Metraipolis › archive › dc_9b984c8236bb
Anlotinib monotherapy in recurrent or metastatic nasopharyngeal carcinoma: a multicenter case-series analysis — Europe PMC PMID:41401065
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41401065
- DOI
- 10.2478/raon-2025-0059
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T15:13:00.341Z
- SHA-256 of the archived text
55b35f9bb82229fd6db42ec6568b368be60e2cc25fb3a089365cf9273b0f2d5c- Stable URL of this page
https://metraipolis.com/documento/dc_9b984c8236bb
How to cite
Anlotinib monotherapy in recurrent or metastatic nasopharyngeal carcinoma: a multicenter case-series analysis — Europe PMC PMID:41401065 — Europe PMC (en), https://europepmc.org/article/MED/41401065 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9b984c8236bb (Metraipolis archive dc_9b984c8236bb, sha256 55b35f9bb82229fd6db42ec6568b368be60e2cc25fb3a089365cf9273b0f2d5c)
BibTeX
@misc{dc9b984c8236bb,
title = {Anlotinib monotherapy in recurrent or metastatic nasopharyngeal carcinoma: a multicenter case-series analysis — Europe PMC PMID:41401065},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41401065},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9b984c8236bb; sha256 55b35f9bb82229fd6db42ec6568b368be60e2cc25fb3a089365cf9273b0f2d5c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41401065. Agents can read the archived copy with the MCP tool read_document.